Bausch + Lomb announced that surgeons can sign up to test drive the new Stellaris Elite vision enhancement system, the company’s next generation phacoemulsification platform, at a wet lab in its booth (#2023) at the Academy Society of Cataract and Refractive Surgery (ASCRS) this week in Los Angeles. The new platform received 510(k) clearance from the FDA in April.
“We know how critical hands-on experience can be when selecting new capital equipment, so we are thrilled to offer our customers the opportunity to test drive this new adaptable, dual-function surgical platform,” Chuck Hess, vice president and general manager, US Surgical, Bausch + Lomb, said in a company news release. “As the industry celebrates 50 years of phacoemulsification, we’re proud to help usher in the future with this innovative technology by demonstrating all of the features this next-generation machine has to offer.”
Among the many new cutting-edge innovations that Stellaris Elite features are Adaptive Fluidics and the Attune energy management systems, which are designed to work synergistically to deliver responsiveness and optimized control throughout the entire procedure. Additionally, while traditional capital equipment has a decade-long life cycle, Stellaris Elite will offer surgeons the opportunity to add upgrades and enhancements continuously, allowing them to customize and expand their capabilities over time to provide optimal performance and long-term visual outcomes for their patients now and in the future. For example, this summer, the company plans to launch Stellaris Elite for retina applications, which will exclusively feature the Vitesse vitreous cutter, the first and only hypersonic, 100% open port vitrectomy system, which represents the first major vitreous removal innovation in 40 years.
During the interactive 30-minute wet lab sessions, surgeons will gain real time, hands-on experience with the new Stellaris Elite platform, as well as the Victus femtosecond laser, and an extremely broad selection of IOLs and delivery systems, which include the iSert delivery system, a market-leading preloaded IOL, and the Crystalens AO, Trulign Toric, and the enVista glistening-free acrylic IOLs. Attendees will have the opportunity to hear firsthand from the engineers and researchers who are responsible for the development of Bausch + Lomb’s surgical suite of technologies.
For more information and to schedule an appointment in the wet lab visit: www.testdrivebausch.com.